1,2,3,4,6-pentakis-O-galloyl-beta-D-glucose and Hypertension

1,2,3,4,6-pentakis-O-galloyl-beta-D-glucose has been researched along with Hypertension in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Graham, D; Guzik, TJ; Justo-Junior, AS; Kiss, AK; Kowalczyk, P; Koziol, J; Kusmierczyk, Z; Luc, K; Maffia, P; Mazur, M; Mikolajczyk, TP; Naruszewicz, M; Nosalski, R; Schramm-Luc, A; Skiba, DS	1

Other Studies

1 other study(ies) available for 1,2,3,4,6-pentakis-O-galloyl-beta-D-glucose and Hypertension

Article	Year
1,2,3,4,6-Penta-O-galloyl-β-d-glucose modulates perivascular inflammation and prevents vascular dysfunction in angiotensin II-induced hypertension. British journal of pharmacology, 2019, Volume: 176, Issue:12 Topics: Angiotensin II; Animals; Humans; Hydrolyzable Tannins; Hypertension; Inflammation; Injections, Subcutaneous; Male; Mice; Mice, Inbred C57BL; Oenothera; Tumor Cells, Cultured; Ventricular Dysfunction	2019

Article

Year

1,2,3,4,6-Penta-O-galloyl-β-d-glucose modulates perivascular inflammation and prevents vascular dysfunction in angiotensin II-induced hypertension.

British journal of pharmacology, 2019, Volume: 176, Issue:12

Topics: Angiotensin II; Animals; Humans; Hydrolyzable Tannins; Hypertension; Inflammation; Injections, Subcutaneous; Male; Mice; Mice, Inbred C57BL; Oenothera; Tumor Cells, Cultured; Ventricular Dysfunction

2019